Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanical characterisation of commercial artificial skin models.
Kho ASK, Béguin S, O'Cearbhaill ED, Ní Annaidh A. Kho ASK, et al. Among authors: beguin s. J Mech Behav Biomed Mater. 2023 Nov;147:106090. doi: 10.1016/j.jmbbm.2023.106090. Epub 2023 Sep 1. J Mech Behav Biomed Mater. 2023. PMID: 37717289
Heparins: A Shift of Paradigm.
Hemker HC, Al Dieri R, Béguin S. Hemker HC, et al. Among authors: beguin s. Front Med (Lausanne). 2019 Nov 15;6:254. doi: 10.3389/fmed.2019.00254. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31803745 Free PMC article.
Separation of blood microsamples by exploiting sedimentation at the microscale.
Forchelet D, Béguin S, Sajic T, Bararpour N, Pataky Z, Frias M, Grabherr S, Augsburger M, Liu Y, Charnley M, Déglon J, Aebersold R, Thomas A, Renaud P. Forchelet D, et al. Among authors: beguin s. Sci Rep. 2018 Sep 20;8(1):14101. doi: 10.1038/s41598-018-32314-4. Sci Rep. 2018. PMID: 30237536 Free PMC article.
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Cuisset T, Grosdidier C, Loundou AD, Quilici J, Loosveld M, Camoin L, Pankert M, Beguin S, Lambert M, Morange PE, Bonnet JL, Alessi MC. Cuisset T, et al. Among authors: beguin s. JACC Cardiovasc Interv. 2013 Aug;6(8):854-63. doi: 10.1016/j.jcin.2013.04.009. JACC Cardiovasc Interv. 2013. PMID: 23968703 Free article.
Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.
Deharo P, Pons C, Pankert M, Bonnet G, Quilici J, Grosdidier C, Beguin S, Morange P, Alessi MC, Bonnet JL, Cuisset T. Deharo P, et al. Among authors: beguin s. Int J Cardiol. 2013 Oct 12;168(5):5004-5. doi: 10.1016/j.ijcard.2013.07.121. Epub 2013 Jul 31. Int J Cardiol. 2013. PMID: 23915522 No abstract available.
Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.
Cuisset T, Cayla G, Quilici J, Pankert M, Deharo P, Bonnet G, Grosdidier C, Beguin S, Morange P, Bonnet JL, Alessi MC. Cuisset T, et al. Among authors: beguin s. Int J Cardiol. 2013 Oct 3;168(3):2988-9. doi: 10.1016/j.ijcard.2013.04.052. Epub 2013 Apr 30. Int J Cardiol. 2013. PMID: 23642612 No abstract available.
131 results